How did Italy’s frontline, Gemelli ART, respond to the COVID-19 pandemic? Hear how they adapted patient care and departmental procedures in radiation oncology to reduce patient encounters with the hospital system, leveraging MRIdian to offer fewer fractions and ablative doses in a time when surgery and chemo were not available to all. Join us to learn how SBRT and MRIdian are reshaping the future of cancer care in a rapidly changing landscape. Q&A will follow the discussion.
The Gemelli ART is the highly specialized center of oncological radiotherapy of the Agostino Gemelli IRCCS University Polyclinic Foundation in Rome, able to offer its patients the most advanced clinical assistance and therapeutic possibilities, being able to make available the most innovative technologies, both on an outpatient basis and that of hospitalization, depending on the needs of the patient.
Davide Cusumano, PhD
Davide Cusumano, PhD, has worked as a medical physicist at Fondazione Policlinico Agostino Gemelli IRCCS in Rome since 2016. His clinical activity is linked to MR-guided and adaptive radiotherapy. In 2020 he received a PhD in "Quantitative analysis of MRI for response prediction and motion quantification" at Università Cattolica del Sacro Cuore. His research activity is focused on MR-guided Radiotherapy, tumor motion management, delta radiomics, and deep learning.
Luca Boldrini, MD
Medical Director; Radiation Oncologist
Luca Boldrini, MD, works as a radiation oncologist at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS of Rome, Italy, where he is involved in the MR-guided radiotherapy research program. His primary research interests include MR-guided radiotherapy, radiomics, imaging applications in the frame of personalized medicine, and innovative technologies implementation in cancer care. He is clinical coordinator of the radiomics research program of the Knowledge Based Oncology Lab (KBO Lab) of Rome, Italy and Scientific Secretary of the Radiomics Working Group of the Italian “Alleanza Contro il Cancro” network. He is currently a PhD student in Oncological Sciences focusing on “radiation oncology, imaging and technological innovation” at the Università Cattolica del Sacro Cuore of Rome, Italy and member of several national and international scientific associations. He also serves as clinical director of the ESTRO In-room MR-Guided Radiotherapy course.